Pre-order Enquiry
Request Free Sample
Global Drugs for HIV Market Research Report 2020
SKU ID : QYR-16548941 | Publishing Date : 13-Oct-2020 | No. of pages : 92
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Drugs for HIV Market Research Report 2020
1 Drugs for HIV Market Overview1.1 Product Overview and Scope of Drugs for HIV
1.2 Drugs for HIV Segment by Type
1.2.1 Global Drugs for HIV Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Integrase Inhibitors
1.2.4 Combination HIV Medicines
1.2.5 Others
1.3 Drugs for HIV Segment by Application
1.3.1 Drugs for HIV Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Drugs for HIV Market Size Estimates and Forecasts
1.4.1 Global Drugs for HIV Revenue 2015-2026
1.4.2 Global Drugs for HIV Sales 2015-2026
1.4.3 Drugs for HIV Market Size by Region: 2020 Versus 2026
1.5 Drugs for HIV Industry
1.6 Drugs for HIV Market Trends
2 Global Drugs for HIV Market Competition by Manufacturers
2.1 Global Drugs for HIV Sales Market Share by Manufacturers (2015-2020)
2.2 Global Drugs for HIV Revenue Share by Manufacturers (2015-2020)
2.3 Global Drugs for HIV Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Drugs for HIV Manufacturing Sites, Area Served, Product Type
2.5 Drugs for HIV Market Competitive Situation and Trends
2.5.1 Drugs for HIV Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Drugs for HIV Players (Opinion Leaders)
3 Drugs for HIV Retrospective Market Scenario by Region
3.1 Global Drugs for HIV Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Drugs for HIV Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Drugs for HIV Market Facts & Figures by Country
3.3.1 North America Drugs for HIV Sales by Country
3.3.2 North America Drugs for HIV Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drugs for HIV Market Facts & Figures by Country
3.4.1 Europe Drugs for HIV Sales by Country
3.4.2 Europe Drugs for HIV Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drugs for HIV Market Facts & Figures by Region
3.5.1 Asia Pacific Drugs for HIV Sales by Region
3.5.2 Asia Pacific Drugs for HIV Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drugs for HIV Market Facts & Figures by Country
3.6.1 Latin America Drugs for HIV Sales by Country
3.6.2 Latin America Drugs for HIV Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Drugs for HIV Market Facts & Figures by Country
3.7.1 Middle East and Africa Drugs for HIV Sales by Country
3.7.2 Middle East and Africa Drugs for HIV Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drugs for HIV Historic Market Analysis by Type
4.1 Global Drugs for HIV Sales Market Share by Type (2015-2020)
4.2 Global Drugs for HIV Revenue Market Share by Type (2015-2020)
4.3 Global Drugs for HIV Price Market Share by Type (2015-2020)
4.4 Global Drugs for HIV Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Drugs for HIV Historic Market Analysis by Application
5.1 Global Drugs for HIV Sales Market Share by Application (2015-2020)
5.2 Global Drugs for HIV Revenue Market Share by Application (2015-2020)
5.3 Global Drugs for HIV Price by Application (2015-2020)
6 Company Profiles and Key Figures in Drugs for HIV Business
6.1 ViiV Healthcare
6.1.1 Corporation Information
6.1.2 ViiV Healthcare Description, Business Overview and Total Revenue
6.1.3 ViiV Healthcare Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.1.4 ViiV Healthcare Products Offered
6.1.5 ViiV Healthcare Recent Development
6.2 Gilead Sciences, Inc
6.2.1 Gilead Sciences, Inc Corporation Information
6.2.2 Gilead Sciences, Inc Description, Business Overview and Total Revenue
6.2.3 Gilead Sciences, Inc Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Gilead Sciences, Inc Products Offered
6.2.5 Gilead Sciences, Inc Recent Development
6.3 Merck Sharp & Dohme Corp
6.3.1 Merck Sharp & Dohme Corp Corporation Information
6.3.2 Merck Sharp & Dohme Corp Description, Business Overview and Total Revenue
6.3.3 Merck Sharp & Dohme Corp Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck Sharp & Dohme Corp Products Offered
6.3.5 Merck Sharp & Dohme Corp Recent Development
6.4 Bristol-Myers Squibb Company
6.4.1 Bristol-Myers Squibb Company Corporation Information
6.4.2 Bristol-Myers Squibb Company Description, Business Overview and Total Revenue
6.4.3 Bristol-Myers Squibb Company Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bristol-Myers Squibb Company Products Offered
6.4.5 Bristol-Myers Squibb Company Recent Development
6.5 Janssen Pharmaceuticals, Inc.
6.5.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.5.2 Janssen Pharmaceuticals, Inc. Description, Business Overview and Total Revenue
6.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Janssen Pharmaceuticals, Inc. Products Offered
6.5.5 Janssen Pharmaceuticals, Inc. Recent Development
6.6 Theratechnologies Inc.
6.6.1 Theratechnologies Inc. Corporation Information
6.6.2 Theratechnologies Inc. Description, Business Overview and Total Revenue
6.6.3 Theratechnologies Inc. Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Theratechnologies Inc. Products Offered
6.6.5 Theratechnologies Inc. Recent Development
6.7 Mylan Pharmaceuticals Inc.
6.6.1 Mylan Pharmaceuticals Inc. Corporation Information
6.6.2 Mylan Pharmaceuticals Inc. Description, Business Overview and Total Revenue
6.6.3 Mylan Pharmaceuticals Inc. Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mylan Pharmaceuticals Inc. Products Offered
6.7.5 Mylan Pharmaceuticals Inc. Recent Development
6.8 Genentech, Inc.
6.8.1 Genentech, Inc. Corporation Information
6.8.2 Genentech, Inc. Description, Business Overview and Total Revenue
6.8.3 Genentech, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Genentech, Inc. Products Offered
6.8.5 Genentech, Inc. Recent Development
6.9 AbbVie Inc.
6.9.1 AbbVie Inc. Corporation Information
6.9.2 AbbVie Inc. Description, Business Overview and Total Revenue
6.9.3 AbbVie Inc. Drugs for HIV Sales, Revenue and Gross Margin (2015-2020)
6.9.4 AbbVie Inc. Products Offered
6.9.5 AbbVie Inc. Recent Development
7 Drugs for HIV Manufacturing Cost Analysis
7.1 Drugs for HIV Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drugs for HIV
7.4 Drugs for HIV Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drugs for HIV Distributors List
8.3 Drugs for HIV Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Drugs for HIV Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drugs for HIV by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Drugs for HIV by Type (2021-2026)
10.2 Drugs for HIV Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drugs for HIV by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Drugs for HIV by Application (2021-2026)
10.3 Drugs for HIV Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drugs for HIV by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Drugs for HIV by Region (2021-2026)
10.4 North America Drugs for HIV Estimates and Projections (2021-2026)
10.5 Europe Drugs for HIV Estimates and Projections (2021-2026)
10.6 Asia Pacific Drugs for HIV Estimates and Projections (2021-2026)
10.7 Latin America Drugs for HIV Estimates and Projections (2021-2026)
10.8 Middle East and Africa Drugs for HIV Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Drugs for HIV Market Research Report 2020
List of TablesTable 1. Global Drugs for HIV Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Drugs for HIV Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Drugs for HIV Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Drugs for HIV Manufacturers Covered in This Study
Table 5. Global Drugs for HIV Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Drugs for HIV Sales Share by Manufacturers (2015-2020)
Table 7. Global Drugs for HIV Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Drugs for HIV Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Drugs for HIV Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Drugs for HIV Sales Sites and Area Served
Table 11. Manufacturers Drugs for HIV Product Types
Table 12. Global Drugs for HIV Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drugs for HIV by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for HIV as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Drugs for HIV Players
Table 16. Global Drugs for HIV Sales (K Units) by Region (2015-2020)
Table 17. Global Drugs for HIV Sales Market Share by Region (2015-2020)
Table 18. Global Drugs for HIV Revenue (Million US$) by Region (2015-2020)
Table 19. Global Drugs for HIV Revenue Market Share by Region (2015-2020)
Table 20. North America Drugs for HIV Sales by Country (2015-2020) (K Units)
Table 21. North America Drugs for HIV Sales Market Share by Country (2015-2020)
Table 22. North America Drugs for HIV Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Drugs for HIV Revenue Market Share by Country (2015-2020)
Table 24. Europe Drugs for HIV Sales by Country (2015-2020) (K Units)
Table 25. Europe Drugs for HIV Sales Market Share by Country (2015-2020)
Table 26. Europe Drugs for HIV Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Drugs for HIV Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Drugs for HIV Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Drugs for HIV Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Drugs for HIV Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Drugs for HIV Revenue Market Share by Region (2015-2020)
Table 32. Latin America Drugs for HIV Sales by Country (2015-2020) (K Units)
Table 33. Latin America Drugs for HIV Sales Market Share by Country (2015-2020)
Table 34. Latin America Drugs for HIV Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Drugs for HIV Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Drugs for HIV Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Drugs for HIV Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Drugs for HIV Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Drugs for HIV Revenue Market Share by Country (2015-2020)
Table 40. Global Drugs for HIV Sales (K Units) by Type (2015-2020)
Table 41. Global Drugs for HIV Sales Share by Type (2015-2020)
Table 42. Global Drugs for HIV Revenue (Million US$) by Type (2015-2020)
Table 43. Global Drugs for HIV Revenue Share by Type (2015-2020)
Table 44. Global Drugs for HIV Price (US$/Unit) by Type (2015-2020)
Table 45. Global Drugs for HIV Sales (K Units) by Application (2015-2020)
Table 46. Global Drugs for HIV Sales Market Share by Application (2015-2020)
Table 47. Global Drugs for HIV Sales Growth Rate by Application (2015-2020)
Table 48. ViiV Healthcare Drugs for HIV Corporation Information
Table 49. ViiV Healthcare Description and Business Overview
Table 50. ViiV Healthcare Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. ViiV Healthcare Main Product
Table 52. ViiV Healthcare Recent Development
Table 53. Gilead Sciences, Inc Drugs for HIV Corporation Information
Table 54. Gilead Sciences, Inc Corporation Information
Table 55. Gilead Sciences, Inc Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Gilead Sciences, Inc Main Product
Table 57. Gilead Sciences, Inc Recent Development
Table 58. Merck Sharp & Dohme Corp Drugs for HIV Corporation Information
Table 59. Merck Sharp & Dohme Corp Corporation Information
Table 60. Merck Sharp & Dohme Corp Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Merck Sharp & Dohme Corp Main Product
Table 62. Merck Sharp & Dohme Corp Recent Development
Table 63. Bristol-Myers Squibb Company Drugs for HIV Corporation Information
Table 64. Bristol-Myers Squibb Company Corporation Information
Table 65. Bristol-Myers Squibb Company Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Bristol-Myers Squibb Company Main Product
Table 67. Bristol-Myers Squibb Company Recent Development
Table 68. Janssen Pharmaceuticals, Inc. Drugs for HIV Corporation Information
Table 69. Janssen Pharmaceuticals, Inc. Corporation Information
Table 70. Janssen Pharmaceuticals, Inc. Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Janssen Pharmaceuticals, Inc. Main Product
Table 72. Janssen Pharmaceuticals, Inc. Recent Development
Table 73. Theratechnologies Inc. Drugs for HIV Corporation Information
Table 74. Theratechnologies Inc. Corporation Information
Table 75. Theratechnologies Inc. Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Theratechnologies Inc. Main Product
Table 77. Theratechnologies Inc. Recent Development
Table 78. Mylan Pharmaceuticals Inc. Drugs for HIV Corporation Information
Table 79. Mylan Pharmaceuticals Inc. Corporation Information
Table 80. Mylan Pharmaceuticals Inc. Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Mylan Pharmaceuticals Inc. Main Product
Table 82. Mylan Pharmaceuticals Inc. Recent Development
Table 83. Genentech, Inc. Drugs for HIV Corporation Information
Table 84. Genentech, Inc. Corporation Information
Table 85. Genentech, Inc. Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Genentech, Inc. Main Product
Table 87. Genentech, Inc. Recent Development
Table 88. AbbVie Inc. Drugs for HIV Corporation Information
Table 89. AbbVie Inc. Corporation Information
Table 90. AbbVie Inc. Drugs for HIV Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. AbbVie Inc. Main Product
Table 92. AbbVie Inc. Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Drugs for HIV Distributors List
Table 96. Drugs for HIV Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Drugs for HIV Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Drugs for HIV Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Drugs for HIV Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Drugs for HIV Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Drugs for HIV Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Drugs for HIV Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Drugs for HIV Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Drugs for HIV Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Drugs for HIV Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Drugs for HIV Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Drugs for HIV
Figure 2. Global Drugs for HIV Sales Market Share by Type: 2020 VS 2026
Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Product Picture
Figure 4. Integrase Inhibitors Product Picture
Figure 5. Combination HIV Medicines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drugs for HIV Consumption Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Others
Figure 12. Global Drugs for HIV Market Size 2015-2026 (US$ Million)
Figure 13. Global Drugs for HIV Sales Capacity (K Units) (2015-2026)
Figure 14. Global Drugs for HIV Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Drugs for HIV Sales Share by Manufacturers in 2020
Figure 16. Global Drugs for HIV Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drugs for HIV Revenue in 2019
Figure 18. Drugs for HIV Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Drugs for HIV Sales Market Share by Region (2015-2020)
Figure 20. Global Drugs for HIV Sales Market Share by Region in 2019
Figure 21. Global Drugs for HIV Revenue Market Share by Region (2015-2020)
Figure 22. Global Drugs for HIV Revenue Market Share by Region in 2019
Figure 23. North America Drugs for HIV Sales Market Share by Country in 2019
Figure 24. North America Drugs for HIV Revenue Market Share by Country in 2019
Figure 25. U.S. Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Drugs for HIV Sales Market Share by Country in 2019
Figure 30. Europe Drugs for HIV Revenue Market Share by Country in 2019
Figure 31. Germany Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Drugs for HIV Sales Market Share by Region in 2019
Figure 42. Asia Pacific Drugs for HIV Revenue Market Share by Region in 2019
Figure 43. China Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Drugs for HIV Sales Market Share by Country in 2019
Figure 66. Latin America Drugs for HIV Revenue Market Share by Country in 2019
Figure 67. Mexico Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Drugs for HIV Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Drugs for HIV Revenue Market Share by Country in 2019
Figure 75. Turkey Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 76. Turkey Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 78. Saudi Arabia Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Drugs for HIV Sales Growth Rate (2015-2020) (K Units)
Figure 80. U.A.E Drugs for HIV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Drugs for HIV by Type (2015-2020)
Figure 82. Sales Market Share of Drugs for HIV by Type in 2019
Figure 83. Revenue Share of Drugs for HIV by Type (2015-2020)
Figure 84. Revenue Market Share of Drugs for HIV by Type in 2019
Figure 85. Global Drugs for HIV Sales Growth by Type (2015-2020) (K Units)
Figure 86. Global Drugs for HIV Sales Market Share by Application (2015-2020)
Figure 87. Global Drugs for HIV Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Drugs for HIV by Application (2015-2020)
Figure 89. Global Revenue Share of Drugs for HIV by Application in 2020
Figure 90. ViiV Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Gilead Sciences, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Merck Sharp & Dohme Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Janssen Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Theratechnologies Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Drugs for HIV
Figure 101. Manufacturing Process Analysis of Drugs for HIV
Figure 102. Drugs for HIV Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Drugs for HIV Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. North America Drugs for HIV Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Drugs for HIV Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Drugs for HIV Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Drugs for HIV Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Drugs for HIV Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Drugs for HIV Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Drugs for HIV Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Drugs for HIV Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Drugs for HIV Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
Keyplayers in Global Drugs for HIV Market Research Report 2020
ViiV HealthcareGilead Sciences, Inc
Merck Sharp & Dohme Corp
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Theratechnologies Inc.
Mylan Pharmaceuticals Inc.
Genentech, Inc.
AbbVie Inc.
